D. Mattia et al., POTASSIUM CHANNEL ACTIVATORS COUNTERACT ANOXIC HYPEREXCITABILITY BUT NOT 4-AMINOPYRIDINE-INDUCED EPILEPTIFORM ACTIVITY IN THE RAT HIPPOCAMPAL SLICE, Neuropharmacology, 33(12), 1994, pp. 1515-1522
The K+ channel activators diazoxide and cromakalim were investigated f
or effects on 4-aminopyridine (4AP)-induced epileptiform activity in a
dult rat hippocampal slices maintained in vitro. Under normal conditio
ns of oxygenation, 4AP (50 mu M) induced two types of field potentials
in extracellular recordings from the CA3 stratum radiatum (apical den
dritic region): epileptiform interictal discharge-like events occurrin
g at a frequency of 0.75 +/- 0.36 Hz and long-lasting negative-going p
otentials mediated by GABA receptor activation that occurred at 0.03 /- 0.01 Hz (n = 36 slices). Neither diazoxide (0.65-1.3 mM, n = 21 sli
ces) nor cromakalim (50-200 mu M, n = 6 slices) altered these two type
s of discharge. Brief periods of anoxia (4-6 min) reduced the frequenc
y of the 4AP-induced interictal-like events (from 0.75 +/- 0.36 Hz to
0.19 +/- 0.15 Hz, n = 20 slices). In 45% of the experiments, the depre
ssant effect of anoxia was preceded by a period of hyperexcitability c
onsisting of a transient (36.1 +/- 12.9 sec) increase in the frequency
of interictal-like events riding on a negative-going DC shift (n = 9
slices). Both responses to anoxia were reversible upon reoxygenation.
In contrast, the rate of occurrence of the GABA-mediated potentials wa
s unaffected by the anoxic episodes. Perfusion with cromakalim (n = 4
slices) or diazoxide (n = 5 slices) abolished the initial period of hy
perexcitability produced by O-2 deprivation but did not alter the subs
equent depression of activity. Our experiments indicate that the K+ ch
annel activators can prevent the initial hyperexcitability produced by
anoxia, but do not influence 4AP-induced epileptiform activity in nor
moxic conditions. These findings suggest that K+ channel opener drugs
might be useful in the treatment of seizures occurring in the setting
of status epilepticus or cerebrovascular disease.